The Head and Neck Steering Committee (HNSC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in adult head and neck cancers. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The HNSC's membership comprises NCTN group representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.
Co-chairs
Christine Chung, M.D.
H. Lee Moffitt Cancer Center
Tampa, FL
Carole Fakhry, M.D., M.P.H.
Johns Hopkins Medical Institute
Baltimore, MD
Loren K. Mell, M.D.
University of California San Diego
La Jolla, CA
Members
Nishant Agrawal, M.D.
University of Chicago
Chicago, IL
Søren M. Bentzen, Ph.D., D.MSc.
University of Maryland School of Medicine
Baltimore, MD
Scott Bratman, M.D., Ph.D.
University of Toronto Princess Margaret Cancer Centre
Toronto, ON, Canada
Barbara Burtness, M.D.
Yale University
New Haven, CT
Joseph N. Contessa, M.D., Ph.D.
Yale University
New Haven, CT
John Hilton, M.D., FRCPC
The Ottawa Hospital Cancer Centre
Ottawa, ON, Canada
Alan L. Ho, M.D., Ph.D.
Memorial Sloan Kettering Cancer Center
New York, NY
Andrew J. Huang, M.D.
Aspirus Cancer Care
Wausau, WI
Edward L. Korn, Ph.D.
National Cancer Institute
Bethesda, MD
Susan Lim, M.S., RN
Patient Advocate
Kirkland, WA
Shakun M. Malik, M.D.
National Cancer Institute
Bethesda, MD
Mei-Yin C. Polley, Ph.D.
University of Chicago
Chicago, IL
Aswanth Reddy, M.B.B.S.
Mercy Hospital
Fort Smith, AR
Lindsay A. Renfro, Ph.D., M.S.
University of Southern California Keck School of Medicine
Monrovia, CA
Jolie Ringash, M.D., M.Sc.
University of Toronto Princess Margaret Cancer Centre
Toronto, ON, Canada
Joseph Salama, M.D.
Duke University Medical Center
Durham, NC
Natalie Silver, M.D., M.S., FACS
Cleveland Clinic
Cleveland, OH
Christina Sisti, D.P.S.
Patient Advocate
Bradenton, FL
Heath D. Skinner, M.D., Ph.D.
University of Pittsburgh Medical Center Hillman Cancer Center
Pittsburgh, PA
Rathan Subramaniam, M.D., Ph.D., M.P.H.
University of Notre Dame
Sydney, Australia
Ammar Sukari, M.D.
Wayne State University Karmanos Cancer Institute
Detroit, MI
Bhadrasain Vikram, M.D.
National Cancer Institute
Bethesda, MD
Trisha M. Wise-Draper, M.D., Ph.D.
University of Cincinnati Cancer Center
Cincinnati, OH
Stuart Wong, M.D.
Medical College of Wisconsin
Milwaukee, WI
Sue S. Yom, M.D., Ph.D., M.A.S.
University of California San Francisco
San Francisco, CA
George Yoo, M.D.
Wayne State University Karmanos Cancer Institute
Detroit, MI
NCI CCCT Program Director
Mehrdad Mohseni, M.D.
mehrdad.mohseni@nih.gov